Skip to main content
BAXTER INTERNATIONAL INC logo

BAXTER INTERNATIONAL INC — Investor Relations & Filings

Ticker · BAX ISIN · US0718131099 LEI · J5OIVXX3P24RJRW5CK77 US Manufacturing
Open in API
Filings indexed 2,456 across all filing types
Latest filing 2016-05-24 Director's Dealing
Country US United States of America
Listing US BAX

About BAXTER INTERNATIONAL INC

https://www.baxter.com/

Baxter International Inc. is a global healthcare company focused on saving and sustaining lives. The company provides a broad portfolio of essential products across renal care, hospital, and surgical settings. Key offerings include technologies for acute and chronic dialysis, sterile intravenous (IV) solutions, infusion systems, clinical nutrition, and critical care. Baxter develops, manufactures, and markets a range of medical devices, connected care solutions, and advanced injectable pharmaceuticals. The company's products are used by healthcare professionals in hospitals, clinics, and homes to provide smarter, more personalized care for patients.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2016-05-24 English
SC TO-I/A Filing
M&A Activity Classification · 100% confidence The document is a Schedule TO filing with the SEC, specifically an Amendment No. 6, related to a tender offer under the Securities Exchange Act of 1934. It details the terms, results, and background of an issuer tender offer by Baxter International Inc. to exchange shares of its common stock. The document includes detailed transaction terms, final results of the tender offer, securities ownership information, and references to related filings such as Form S-4 and proxy statements. This type of filing is a tender offer statement, which is a regulatory filing related to M&A activity, specifically a takeover bid or exchange offer. The presence of Rule 14d-100 and Rule 13e-4 references confirms this is a tender offer statement. Therefore, the appropriate classification is M&A Activity (TAR). The document length and content confirm it is not a brief announcement or a proxy statement but a detailed tender offer filing.
2016-05-24 English
425 Filing
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the final results of an exchange offer by Baxter International Inc. for shares of Baxalta common stock. It includes details about the number of shares tendered, proration factors, and the process for delivering shares. The document references filings with the SEC such as Form S-4 and Schedule TO but does not contain actual financial statements or detailed financial analysis. It is an announcement of the outcome of a capital transaction (exchange offer) rather than the transaction itself or a detailed financing update. Given the nature of the content—final results of an exchange offer—and the focus on capital structure changes, the document best fits the category of Capital/Financing Update (CAP). The document length (6854 characters) supports it being a full announcement rather than a brief notice or report publication announcement. Therefore, the classification is CAP with high confidence.
2016-05-24 English
SC TO-I/A Filing
Merger & Acquisition Classification · 100% confidence The document is a Schedule TO filing under Rule 14d-100 related to a tender offer by Baxter International Inc. It includes detailed information about the terms of the exchange offer, securities involved, transaction details, and references to related prospectuses and registration statements. The document is a formal regulatory filing concerning a tender offer transaction, which is a type of merger and acquisition activity. It is not an annual report, earnings release, or proxy statement, but specifically a tender offer statement under the Securities Exchange Act of 1934. Therefore, the appropriate classification is 'Merger & Acquisition' (MA). The document length and content confirm it is the actual filing, not just an announcement or certification.
2016-05-19 English
425 Filing
Merger & Acquisition Classification · 95% confidence The document references Rule 425 under the Securities Act of 1933, which is commonly used for merger communications and tender offers. It mentions an offer by Baxter International Inc. to exchange shares of Baxalta Incorporated for Baxter shares, indicating a merger or acquisition-related communication. The text is brief and appears to be a filing related to merger communications rather than a full report or announcement. Therefore, the document fits the category of Merger & Acquisition filings (MA).
2016-05-19 English
425 Filing
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the preliminary results of an exchange offer by Baxter International Inc. It details the number of shares tendered, accepted, and the proration process. The document references filings with the SEC such as Form S-4 and Schedule TO but does not contain actual financial statements or detailed financial analysis. It is an announcement of the results of a capital transaction (exchange offer) rather than the transaction itself or a detailed financing update. The content fits best under Capital/Financing Update (CAP) as it provides an update on a financing-related activity (exchange offer results). The document length is 7,626 characters, which is sufficient for a detailed announcement but not a full report. Therefore, the classification is CAP with high confidence.
2016-05-19 English

Browse filings by year

33 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.